Sign in
CLAZF Stock Price, Chart, Stats & News
Claritas Pharmaceuticals, Inc.
Save
Claritas Pharmaceuticals, Inc. (CLAZF) does not currently pay a dividend.
3,659
Market cap
–
Current P/E
–
Forward P/E
CLAZF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Similar securities
Based on sector and market capitalization
Report issue